A Working Memory Training to Decrease Rumination in Depressed and Anxious Individuals
NCT ID: NCT02119975
Last Updated: 2014-04-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
98 participants
INTERVENTIONAL
2011-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cognitive Control Training for Extinction in PTSD
NCT06629064
Cognitive Training for Mood and Anxiety Disorders
NCT02256566
fMRI in Posttraumatic Stress Disorder (PTSD) During Working Memory Updating
NCT00288314
Emotional Working Memory Training for Veterans With PTSD Symptoms
NCT02766296
Influence of the Noradrenergic System on the Formation of Intrusive Memories
NCT02541071
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo working memory training
Placebo training
Working memory training
Working memory training
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Working memory training
Placebo training
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Anxiety diagnosis
Exclusion Criteria
* Substance abuse
18 Years
67 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Erasmus Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ingmar Franken
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Erasmus University Rotterdam
Rotterdam, South Holland, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
4
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.